ClinicalTrials.Veeva

Menu

Muscle Preservation Hamstring Graft for ACL Reconstruction

H

Hanyang University Seoul Hospital

Status

Unknown

Conditions

Graft Healing

Treatments

Procedure: No muscle preservation
Procedure: Muscle preservation

Study type

Interventional

Funder types

Other

Identifiers

NCT03998904
muscle preservation study

Details and patient eligibility

About

  • Muscle derived stem cell is a better source of stem cells than a tendon tissue
  • Preservation of muscle derived stem cell may enhance bone-tendon integration and ligamentization of ACL hamstring graft

Enrollment

28 estimated patients

Sex

All

Ages

16 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Primary ACL reconstruction using autogenous hamstring graft

Exclusion criteria

  • Combined meniscal or ligament surgery
  • Combined osteoarthritis (KL grade II or more)
  • chondral injury more than grade 2
  • Refuse to undergo MRI

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

28 participants in 2 patient groups

Muscle preservation
Experimental group
Description:
Muscle preservation for hamsting graft
Treatment:
Procedure: Muscle preservation
None preservation
Active Comparator group
Description:
No muscle preservation for hamstring graft
Treatment:
Procedure: No muscle preservation

Trial contacts and locations

1

Loading...

Central trial contact

JIN KYU LEE, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems